C E Clarke Selected Research

Parkinson Disease (Parkinson's Disease)

01/2004	Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease.
01/2004	Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease.
01/2003	Dopamine agonist monotherapy in early Parkinson's disease.
01/2003	Amantadine in Parkinson's disease.
01/2003	Amantadine for dyskinesia in Parkinson's disease.
11/2002	Dopamine agonist monotherapy in Parkinson's disease.
01/2002	Uncertainties in the pharmacotherapy of Parkinson's disease and how to solve them.
05/2001	A randomized, double-blind, placebo-controlled, ascending-dose tolerability and safety study of remacemide as adjuvant therapy in Parkinson's disease with response fluctuations.
01/2001	A comparison of physiotherapy techniques for patients with Parkinson's disease.
01/2001	Ropinirole for levodopa-induced complications in Parkinson's disease.
01/2001	Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease.
01/2001	Cabergoline for levodopa-induced complications in Parkinson's disease.
01/2001	Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease.
01/2001	Speech and language therapy for dysarthria in Parkinson's disease.
01/2001	A comparison of speech and language therapy techniques for dysarthria in Parkinson's disease.
01/2001	Occupational therapy for patients with Parkinson's disease.
11/2000	Systematic review of acute levodopa and apomorphine challenge tests in the diagnosis of idiopathic Parkinson's disease.
11/2000	Basal ganglia metabolite concentrations in idiopathic Parkinson's disease and multiple system atrophy measured by proton magnetic resonance spectroscopy.
05/2000	A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group.
01/2000	Lisuride for levodopa-induced complications in Parkinson's disease.
01/2000	Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease.
01/2000	Lisuride versus bromocriptine for levodopa-induced complications in Parkinson's disease.
01/2000	Ropinirole for levodopa-induced complications in Parkinson's disease.

Articles by Research Topic

Disease

23	Parkinson Disease (Parkinson's Disease) 01/2004 - 01/2000
2	Dyskinesias (Dyskinesia) 01/2003 - 05/2000
2	Dysarthria (Spastic Dysarthria) 01/2001 - 01/2001
1	Tremor (Tremors) 07/2004
1	Parkinsonian Disorders (Parkinsonism) 11/2001
1	Multiple System Atrophy 11/2000

Drug/Important Bio-Agent (IBA)

12	Levodopa (L Dopa)FDA LinkGeneric 01/2004 - 01/2000
5	ropinirole (Requip)FDA LinkGeneric 01/2001 - 01/2000
4	Bromocriptine (Parlodel)FDA LinkGeneric 01/2001 - 01/2000
2	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2004 - 01/2004
2	Dopamine Agonists (Dopamine Agonist)IBA 01/2003 - 11/2002
2	Amantadine (Aman)FDA LinkGeneric 01/2003 - 01/2003
2	Protons (Proton)IBA 11/2001 - 11/2000
2	cabergoline FDA LinkGeneric 01/2001 - 01/2001
2	LisurideIBA 01/2000 - 01/2000
1	alpha-methylacyl-CoA racemaseIBA 07/2004
1	remacemideIBA 05/2001
1	ApomorphineIBA 11/2000

Therapy/Procedure

2	Language Therapy (Language Training) 01/2001 - 01/2001
1	Drug Therapy (Chemotherapy) 01/2002
1	Occupational Therapy (Therapy, Occupational) 01/2001
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2001